Method and Device for Screening Congenital Heart Disease in Newborns
|Organization:||Los Angeles Biomedical Institute at Harbor-UCLA Medical Center, CA, US|
|I.P. Brief:||The current invention, Cardioscreen, is a device designed for screening congenital heart disease in newborns prior to discharge from the hospital nursery. Cardioscreen will integrate pulse oximetry, electrocardiogram (ECG), and phonocardiogram into a device with built-in diagnostic algorithm and management guidelines for practitioners. |
|Keywords:||heart, infant, screening, medical device|
|Primary Industry:||Health & Medical Devices|
|Specific Market:||newborn screening in hospital nurseries and pediatrician\'s offices|
Full IP Descriptions available on-site.